BioVersys AG (FRA:W33) Days Inventory: 0.00 (As of Dec. 2025)


FRA:W33 BioVersys AG FRA:W33
7 GF Score
Price €28.40
View Full Analysis

What is BioVersys AG Days Inventory?

BioVersys AG FRA:W33 +1.43% 7 Days Inventory is 0.00 as of Dec. 2025. GuruFocus rates FRA:W33 with a GF Score™ of 7/100. Among 635 Biotechnology companies, BioVersys AG ranks worse than 157480.16% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). BioVersys AG's Average Total Inventories for the six months ended in Dec. 2025 was €0.00 Mil. BioVersys AG's Cost of Goods Sold for the six months ended in Dec. 2025 was €1.57 Mil. Hence, BioVersys AG's Days Inventory for the six months ended in Dec. 2025 was 0.00.

The historical rank and industry rank for BioVersys AG's Days Inventory or its related term are showing as below:

FRA:W33's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 183.23
* Ranked among companies with meaningful Days Inventory only.

BioVersys AG's Days Inventory stayed the same from Dec. 2024 (0.00) to Dec. 2025 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BioVersys AG's Inventory-to-Revenue for the six months ended in Dec. 2025 was 0.00.

BioVersys AG  (FRA:W33) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

BioVersys AG's Inventory Turnover for the six months ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=1.574 / 0
=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BioVersys AG's Inventory to Revenue for the six months ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0 / 0.857
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

BioVersys AG Days Inventory Related Terms

BioVersys AG Days Inventory Historical Data

* Premium members only.

The historical data trend for BioVersys AG's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioVersys AG Days Inventory Chart

BioVersys AG Annual Data
Trend Dec24 Dec25
Days Inventory
0.00 0.00

BioVersys AG Semi-Annual Data
Jun24 Dec24 Jun25 Dec25
Days Inventory 0.00 0.00 0.00 0.00

FRA:W33 vs VRTX, REGN, ALNY: Days Inventory Comparison

For the Biotechnology subindustry, BioVersys AG's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioVersys AG Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioVersys AG's Days Inventory distribution charts can be found below:

* The bar in red indicates where BioVersys AG's Days Inventory falls into.


FRA:W33
7GF Score
BioVersys AG FRA:W33
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioVersys AG Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BioVersys AG's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 4.172*365
=0 / 4.172*365
=0.00

BioVersys AG's Days Inventory for the quarter that ended in Dec. 2025 is calculated as:

Days Inventory (Q: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2025 ) + Total Inventories (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 1.574*365 / 2
=0 / 1.574*365 / 2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 0.00 mean?
BioVersys AG (FRA:W33) has a Days Inventory of 0.00 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BioVersys AG and its competitors. According to the industry distribution chart, BioVersys AG ranks #999999 out of 635 companies in the Biotechnology industry.
Is BioVersys AG's Days Inventory too high?
BioVersys AG's current Days Inventory is 0.00. Based on the distribution chart, BioVersys AG ranks #999999 out of 635 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, BioVersys AG has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does BioVersys AG's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BioVersys AG ranks #999999 out of 635 companies for Days Inventory. This places BioVersys AG in the lower half of its industry. The industry median Days Inventory is 183.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BioVersys AG and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioVersys AG's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioVersys AG stock overvalued right now?
BioVersys AG (FRA:W33) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. BioVersys AG's overall GF Score™ is 7/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For BioVersys AG (FRA:W33), the current Days Inventory is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioVersys AG Business Description

Other Exchanges BIOVz:UKBIOV:Switzerland
Address c/o Technologiepark, Hochbergerstrasse 60c, Basel, CHE, CH-4057
BioVersys AG is a multi-asset, clinical-stage biopharmaceutical company. The Group focuses on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The pipeline products of the company include BV100 - novel MoA, Alpibectir - novel potentiator MoA, BV200 - novel anti-virulence MoA, BV500 - novel series, and others. It has one operating segment focusing on the research and development and prospective commercialization of antibiotics. Geographically, the company operates in Switzerland and France.
7GF Score

Get the complete analysis for FRA:W33

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€28.40
Price